HEADER OXIDOREDUCTASE 30-NOV-06 2O2S TITLE THE STRUCTURE OF T. GONDII ENOYL ACYL CARRIER PROTEIN REDUCTASE IN TITLE 2 COMPLEX WITH NAD AND TRICLOSAN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-ACYL CARRIER REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 103-417; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TOXOPLASMA GONDII; SOURCE 3 ORGANISM_TAXID: 383379; SOURCE 4 STRAIN: RH; SOURCE 5 GENE: ENR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 STAR (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMALC2X KEYWDS ENOYL REDUCTASE, TRICLOSAN, ROSSMANN FOLD, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR S.P.MUENCH,S.T.PRIGGE,R.MCLEOD,J.B.RAFFERTY,M.J.KIRISITS,C.W.ROBERTS, AUTHOR 2 E.J.MUI,D.W.RICE REVDAT 5 25-OCT-23 2O2S 1 REMARK REVDAT 4 13-JUL-11 2O2S 1 VERSN REVDAT 3 24-FEB-09 2O2S 1 VERSN REVDAT 2 13-MAR-07 2O2S 1 JRNL REVDAT 1 26-DEC-06 2O2S 0 JRNL AUTH S.P.MUENCH,S.T.PRIGGE,R.MCLEOD,J.B.RAFFERTY,M.J.KIRISITS, JRNL AUTH 2 C.W.ROBERTS,E.J.MUI,D.W.RICE JRNL TITL STUDIES OF TOXOPLASMA GONDII AND PLASMODIUM FALCIPARUM ENOYL JRNL TITL 2 ACYL CARRIER PROTEIN REDUCTASE AND IMPLICATIONS FOR THE JRNL TITL 3 DEVELOPMENT OF ANTIPARASITIC AGENTS JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 63 328 2007 JRNL REFN ISSN 0907-4449 JRNL PMID 17327670 JRNL DOI 10.1107/S0907444906053625 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.P.MUENCH,S.T.PRIGGE,L.ZHU,M.J.KIRISITS,C.W.ROBERTS, REMARK 1 AUTH 2 S.WERNIMONT,R.MCLEOD,D.W.RICE REMARK 1 TITL EXPRESSION, PURIFICATION AND PRELIMINARY CRYSTALLOGRAPHIC REMARK 1 TITL 2 ANALYSIS OF THE TOXOPLASMA GONDII ENOYL REDUCTASE REMARK 1 REF ACTA CRYSTALLOGR.,SECT.F V. 62 604 2006 REMARK 1 REFN ESSN 1744-3091 REMARK 1 PMID 16754994 REMARK 1 DOI 10.1107/S1744309106018112 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 19990 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1080 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1401 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.80 REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE SET COUNT : 87 REMARK 3 BIN FREE R VALUE : 0.3470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4514 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 122 REMARK 3 SOLVENT ATOMS : 36 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.86000 REMARK 3 B22 (A**2) : 3.86000 REMARK 3 B33 (A**2) : -5.79000 REMARK 3 B12 (A**2) : 1.93000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.049 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.342 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.264 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.006 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.916 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4753 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4271 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6468 ; 1.621 ; 2.001 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9918 ; 0.950 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 605 ; 7.065 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 187 ;36.230 ;23.743 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 722 ;17.380 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 28 ;17.035 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 709 ; 0.105 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5355 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 963 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1046 ; 0.223 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 4343 ; 0.183 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2298 ; 0.186 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2834 ; 0.088 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 115 ; 0.174 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 27 ; 0.099 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 140 ; 0.230 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 25 ; 0.293 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3054 ; 0.573 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1250 ; 0.119 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4763 ; 0.990 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1946 ; 1.331 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1705 ; 2.134 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 4 A 305 5 REMARK 3 1 B 3 B 305 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1765 ; 0.20 ; 0.50 REMARK 3 LOOSE POSITIONAL 1 A (A): 2577 ; 0.56 ; 5.00 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1765 ; 0.69 ; 2.00 REMARK 3 LOOSE THERMAL 1 A (A**2): 2577 ; 1.26 ; 10.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2O2S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 05-DEC-06. REMARK 100 THE DEPOSITION ID IS D_1000040614. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21105 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.48000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2O2Y REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL, 6% PEG 8000, PH 9.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 125.30333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.65167 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.65167 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 125.30333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 24600 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -215.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 135.22987 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 62.65167 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 ALA A 2 REMARK 465 PHE A 3 REMARK 465 LEU A 307 REMARK 465 GLN A 308 REMARK 465 ARG A 309 REMARK 465 ALA A 310 REMARK 465 THR A 311 REMARK 465 GLN A 312 REMARK 465 GLU A 313 REMARK 465 ILE A 314 REMARK 465 ASN A 315 REMARK 465 SER B 1 REMARK 465 ALA B 2 REMARK 465 SER B 238 REMARK 465 GLY B 239 REMARK 465 LEU B 307 REMARK 465 GLN B 308 REMARK 465 ARG B 309 REMARK 465 ALA B 310 REMARK 465 THR B 311 REMARK 465 GLN B 312 REMARK 465 GLU B 313 REMARK 465 ILE B 314 REMARK 465 ASN B 315 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 64 CE NZ REMARK 470 LYS A 94 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 183 OH TYR B 287 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD2 ASP B 300 OG SER B 303 5675 1.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER A 303 C MET A 304 N -0.200 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 304 O - C - N ANGL. DEV. = -14.3 DEGREES REMARK 500 PRO B 305 C - N - CD ANGL. DEV. = -18.1 DEGREES REMARK 500 PRO B 306 C - N - CD ANGL. DEV. = -17.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 67 12.77 -67.24 REMARK 500 SER A 69 -169.19 -79.62 REMARK 500 ASP A 95 34.75 -97.62 REMARK 500 GLU A 170 132.97 -36.95 REMARK 500 LYS A 237 113.81 -39.34 REMARK 500 SER A 238 -127.54 -110.02 REMARK 500 ASP A 289 24.90 -148.49 REMARK 500 GLN A 297 130.79 177.47 REMARK 500 ALA B 74 43.35 -83.84 REMARK 500 LEU B 79 113.38 -161.49 REMARK 500 ASN B 96 126.30 -23.15 REMARK 500 ASP B 289 23.35 -155.14 REMARK 500 MET B 304 -145.29 -122.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO A 4 ILE A 5 136.47 REMARK 500 LYS A 237 SER A 238 146.50 REMARK 500 LYS B 241 SER B 242 -139.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TCL A 705 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TCL B 706 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1D7O RELATED DB: PDB REMARK 900 THE SAME PROTEIN FROM B. NAPUS COMPLEXED WITH NAD AND TRICLOSAN REMARK 900 RELATED ID: 1NHG RELATED DB: PDB REMARK 900 THE SAME PROTEIN FROM P. FALCIPARUM IN COMPLEX WITH TRICLOSAN REMARK 900 RELATED ID: 1D8A RELATED DB: PDB REMARK 900 THE SAME PROTEIN FROM E. COLI IN COMPLEX WITH NAD AND TRICLOSAN REMARK 900 RELATED ID: 1JVF RELATED DB: PDB REMARK 900 THE SAME PROTEIN FROM H. PYLORI REMARK 900 RELATED ID: 2O2Y RELATED DB: PDB REMARK 900 THE SAME PROTEIN FROM P. FALCIPARUM IN COMPLEX WITH NAD AND REMARK 900 TRICLOSAN REMARK 900 RELATED ID: 2O50 RELATED DB: PDB REMARK 900 THE SAME PROTEIN FROM T. GONDII WITHOUT LIGAND DBREF 2O2S A 1 315 UNP Q6UCJ9 Q6UCJ9_TOXGO 103 417 DBREF 2O2S B 1 315 UNP Q6UCJ9 Q6UCJ9_TOXGO 103 417 SEQRES 1 A 315 SER ALA PHE PRO ILE ASP LEU ARG GLY GLN THR ALA PHE SEQRES 2 A 315 VAL ALA GLY VAL ALA ASP SER HIS GLY TYR GLY TRP ALA SEQRES 3 A 315 ILE ALA LYS HIS LEU ALA SER ALA GLY ALA ARG VAL ALA SEQRES 4 A 315 LEU GLY THR TRP PRO PRO VAL LEU GLY LEU PHE GLN LYS SEQRES 5 A 315 SER LEU GLN SER GLY ARG LEU ASP GLU ASP ARG LYS LEU SEQRES 6 A 315 PRO ASP GLY SER LEU ILE GLU PHE ALA GLY VAL TYR PRO SEQRES 7 A 315 LEU ASP ALA ALA PHE ASP LYS PRO GLU ASP VAL PRO GLN SEQRES 8 A 315 ASP ILE LYS ASP ASN LYS ARG TYR ALA GLY VAL ASP GLY SEQRES 9 A 315 TYR THR ILE LYS GLU VAL ALA VAL LYS VAL LYS GLN ASP SEQRES 10 A 315 LEU GLY ASN ILE ASP ILE LEU VAL HIS SER LEU ALA ASN SEQRES 11 A 315 GLY PRO GLU VAL THR LYS PRO LEU LEU GLU THR SER ARG SEQRES 12 A 315 LYS GLY TYR LEU ALA ALA SER SER ASN SER ALA TYR SER SEQRES 13 A 315 PHE VAL SER LEU LEU GLN HIS PHE GLY PRO ILE MET ASN SEQRES 14 A 315 GLU GLY GLY SER ALA VAL THR LEU SER TYR LEU ALA ALA SEQRES 15 A 315 GLU ARG VAL VAL PRO GLY TYR GLY GLY GLY MET SER SER SEQRES 16 A 315 ALA LYS ALA ALA LEU GLU SER ASP THR ARG THR LEU ALA SEQRES 17 A 315 TRP GLU ALA GLY GLN LYS TYR GLY VAL ARG VAL ASN ALA SEQRES 18 A 315 ILE SER ALA GLY PRO LEU LYS SER ARG ALA ALA SER ALA SEQRES 19 A 315 ILE GLY LYS SER GLY GLU LYS SER PHE ILE ASP TYR ALA SEQRES 20 A 315 ILE ASP TYR SER TYR ASN ASN ALA PRO LEU ARG ARG ASP SEQRES 21 A 315 LEU HIS SER ASP ASP VAL GLY GLY ALA ALA LEU PHE LEU SEQRES 22 A 315 LEU SER PRO LEU ALA ARG ALA VAL SER GLY VAL THR LEU SEQRES 23 A 315 TYR VAL ASP ASN GLY LEU HIS ALA MET GLY GLN ALA VAL SEQRES 24 A 315 ASP SER ARG SER MET PRO PRO LEU GLN ARG ALA THR GLN SEQRES 25 A 315 GLU ILE ASN SEQRES 1 B 315 SER ALA PHE PRO ILE ASP LEU ARG GLY GLN THR ALA PHE SEQRES 2 B 315 VAL ALA GLY VAL ALA ASP SER HIS GLY TYR GLY TRP ALA SEQRES 3 B 315 ILE ALA LYS HIS LEU ALA SER ALA GLY ALA ARG VAL ALA SEQRES 4 B 315 LEU GLY THR TRP PRO PRO VAL LEU GLY LEU PHE GLN LYS SEQRES 5 B 315 SER LEU GLN SER GLY ARG LEU ASP GLU ASP ARG LYS LEU SEQRES 6 B 315 PRO ASP GLY SER LEU ILE GLU PHE ALA GLY VAL TYR PRO SEQRES 7 B 315 LEU ASP ALA ALA PHE ASP LYS PRO GLU ASP VAL PRO GLN SEQRES 8 B 315 ASP ILE LYS ASP ASN LYS ARG TYR ALA GLY VAL ASP GLY SEQRES 9 B 315 TYR THR ILE LYS GLU VAL ALA VAL LYS VAL LYS GLN ASP SEQRES 10 B 315 LEU GLY ASN ILE ASP ILE LEU VAL HIS SER LEU ALA ASN SEQRES 11 B 315 GLY PRO GLU VAL THR LYS PRO LEU LEU GLU THR SER ARG SEQRES 12 B 315 LYS GLY TYR LEU ALA ALA SER SER ASN SER ALA TYR SER SEQRES 13 B 315 PHE VAL SER LEU LEU GLN HIS PHE GLY PRO ILE MET ASN SEQRES 14 B 315 GLU GLY GLY SER ALA VAL THR LEU SER TYR LEU ALA ALA SEQRES 15 B 315 GLU ARG VAL VAL PRO GLY TYR GLY GLY GLY MET SER SER SEQRES 16 B 315 ALA LYS ALA ALA LEU GLU SER ASP THR ARG THR LEU ALA SEQRES 17 B 315 TRP GLU ALA GLY GLN LYS TYR GLY VAL ARG VAL ASN ALA SEQRES 18 B 315 ILE SER ALA GLY PRO LEU LYS SER ARG ALA ALA SER ALA SEQRES 19 B 315 ILE GLY LYS SER GLY GLU LYS SER PHE ILE ASP TYR ALA SEQRES 20 B 315 ILE ASP TYR SER TYR ASN ASN ALA PRO LEU ARG ARG ASP SEQRES 21 B 315 LEU HIS SER ASP ASP VAL GLY GLY ALA ALA LEU PHE LEU SEQRES 22 B 315 LEU SER PRO LEU ALA ARG ALA VAL SER GLY VAL THR LEU SEQRES 23 B 315 TYR VAL ASP ASN GLY LEU HIS ALA MET GLY GLN ALA VAL SEQRES 24 B 315 ASP SER ARG SER MET PRO PRO LEU GLN ARG ALA THR GLN SEQRES 25 B 315 GLU ILE ASN HET NAD A 500 44 HET TCL A 705 17 HET NAD B 501 44 HET TCL B 706 17 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM TCL TRICLOSAN FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 4 TCL 2(C12 H7 CL3 O2) FORMUL 7 HOH *36(H2 O) HELIX 1 1 GLY A 22 SER A 33 1 12 HELIX 2 2 TRP A 43 GLY A 57 1 15 HELIX 3 3 LEU A 59 LYS A 64 1 6 HELIX 4 4 PRO A 90 ASP A 95 1 6 HELIX 5 5 ASN A 96 ALA A 100 5 5 HELIX 6 6 THR A 106 GLY A 119 1 14 HELIX 7 7 PRO A 137 THR A 141 5 5 HELIX 8 8 SER A 142 ALA A 154 1 13 HELIX 9 9 ALA A 154 GLY A 165 1 12 HELIX 10 10 ALA A 181 GLU A 183 5 3 HELIX 11 11 GLY A 192 TYR A 215 1 24 HELIX 12 12 SER A 229 ILE A 235 1 7 HELIX 13 13 SER A 242 ALA A 255 1 14 HELIX 14 14 HIS A 262 LEU A 274 1 13 HELIX 15 15 SER A 275 ARG A 279 5 5 HELIX 16 16 GLY A 291 MET A 295 5 5 HELIX 17 17 GLY B 22 ALA B 34 1 13 HELIX 18 18 TRP B 43 SER B 56 1 14 HELIX 19 19 LYS B 85 VAL B 89 5 5 HELIX 20 20 PRO B 90 ASN B 96 1 7 HELIX 21 21 THR B 106 GLY B 119 1 14 HELIX 22 22 PRO B 137 THR B 141 5 5 HELIX 23 23 SER B 142 ALA B 154 1 13 HELIX 24 24 ALA B 154 GLY B 165 1 12 HELIX 25 25 TYR B 179 GLU B 183 5 5 HELIX 26 26 GLY B 192 GLY B 216 1 25 HELIX 27 27 SER B 229 ALA B 234 1 6 HELIX 28 28 SER B 242 ALA B 255 1 14 HELIX 29 29 HIS B 262 LEU B 274 1 13 HELIX 30 30 SER B 275 ARG B 279 5 5 HELIX 31 31 GLY B 291 MET B 295 5 5 SHEET 1 A 7 VAL A 76 PRO A 78 0 SHEET 2 A 7 ARG A 37 THR A 42 1 N LEU A 40 O TYR A 77 SHEET 3 A 7 THR A 11 ALA A 15 1 N ALA A 12 O ARG A 37 SHEET 4 A 7 ILE A 121 HIS A 126 1 O ASP A 122 N THR A 11 SHEET 5 A 7 MET A 168 TYR A 179 1 O VAL A 175 N HIS A 126 SHEET 6 A 7 ARG A 218 ALA A 224 1 O ARG A 218 N GLY A 172 SHEET 7 A 7 THR A 285 VAL A 288 1 O LEU A 286 N ALA A 221 SHEET 1 B 7 VAL B 76 PRO B 78 0 SHEET 2 B 7 ARG B 37 THR B 42 1 N THR B 42 O TYR B 77 SHEET 3 B 7 THR B 11 ALA B 15 1 N ALA B 12 O ARG B 37 SHEET 4 B 7 ILE B 121 HIS B 126 1 O ILE B 123 N PHE B 13 SHEET 5 B 7 MET B 168 SER B 178 1 O VAL B 175 N HIS B 126 SHEET 6 B 7 ASN B 220 ALA B 224 1 O ASN B 220 N ALA B 174 SHEET 7 B 7 THR B 285 VAL B 288 1 O LEU B 286 N ALA B 221 SITE 1 AC1 22 ALA A 18 GLY A 22 TYR A 23 TRP A 43 SITE 2 AC1 22 LEU A 79 ASP A 80 ALA A 81 SER A 127 SITE 3 AC1 22 LEU A 128 ALA A 129 ASN A 130 ASN A 152 SITE 4 AC1 22 LEU A 177 SER A 178 TYR A 179 LYS A 197 SITE 5 AC1 22 GLY A 225 PRO A 226 LEU A 227 SER A 229 SITE 6 AC1 22 ALA A 231 TCL A 705 SITE 1 AC2 24 GLY B 16 ALA B 18 GLY B 22 TYR B 23 SITE 2 AC2 24 TRP B 43 LEU B 79 ASP B 80 ALA B 81 SITE 3 AC2 24 SER B 127 LEU B 128 ALA B 129 ASN B 130 SITE 4 AC2 24 LEU B 177 SER B 178 LYS B 197 ALA B 224 SITE 5 AC2 24 GLY B 225 PRO B 226 LEU B 227 SER B 229 SITE 6 AC2 24 ARG B 230 ALA B 231 TCL B 706 HOH B 715 SITE 1 AC3 6 ALA A 129 GLY A 131 TYR A 179 TYR A 189 SITE 2 AC3 6 ALA A 231 NAD A 500 SITE 1 AC4 6 ALA B 129 GLY B 131 TYR B 189 MET B 193 SITE 2 AC4 6 ALA B 231 NAD B 501 CRYST1 78.075 78.075 187.955 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012808 0.007395 0.000000 0.00000 SCALE2 0.000000 0.014790 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005320 0.00000